Investigation of the Effect of Training on the Side Effects of Chemotherapy Given Via the Mobile Health Application on the Quality of Life in Colorectal Cancer Patients

NCT05940740 | Completed

• 1 other identifier: 2022.10.13-34
• Study Type: interventional
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

The incidence of colorectal cancer ranks fourth worldwide after lung, prostate and breast cancers. Although chemotherapy has an important place in the treatment of colorectal cancers, it can cause side effects such as diarrhea and fatigue in patients. Cancer patients' ability to cope with treatment side effects can be benefited from technological developments. Studies have shown that mobile health applications reduce symptom experience and increase quality of life in patients with breast cancer and leukemia.

Conditions

Colorectal Cancer; Mobile Phone Use; Nurse's Role

Keywords

Colorectal Cancer

Outcome Measures

Primary Outcomes (3)

• Functional Assessment of Cancer Therapy-Colorectal

  The Functional Assessment of Cancer Therapy-Colorectal Scale was first developed by Ward et al. in 1999 in the USA by the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. The scale consists of a total of 5 dimensions and a total of 46 items. The scale consists of Ordinary Physical Status sub-dimension, Social Life and Family Status sub-dimension, intense Status sub-dimension, Activity Status sub-dimension and Other Concerns sub-dimensions. In the evaluation made with the FACT-C Scale, the subject is asked to answer each statement by observing the last 7th day indicator. Each item of the scale is evaluated on a 5-point Likert-type scale ("never" = 0, "very little" = 1, "some" = 2, "quite" = 3, "a lot" = 4). Its total score is between 0-136.

  Two weeks

• Patient Information Form

  The Patient Information Form was prepared considering the factors that may affect the self-care of patients diagnosed with colorectal cancer who underwent outpatient chemotherapy within a year. This form consists of a total of 19 questions questioning the characteristics of the individual, the disease and the treatment.

  Two weeks

• Nightingale Symptom Evaluation Scale

  The Nightingale Symptom Evaluation Scale (2009) was developed by Can and Aydıner for patients diagnosed with cancer. The scale includes three sub-dimensions. These sub-dimensions are "Physical Well-Being", "Social Well-Being" and "Psychological Well-Being". The answers given by the patients to the scale are scored from 0 to 4 and answered on a five-point Likert type scale. Patients are asked to evaluate these questions by choosing one of the points "No" "0 points", "Very little" "1 point", "A little" "2 points", "Quite" "3 points", "Too much" "4 points".

  Two weeks

Secondary Outcomes (1)

• Self-Care Needs Evaluation Form

  Two weeks

Study Arms (2)

INTERFERENCE (EXPERIMENT)

EXPERIMENTAL

1. Giving patients with colorectal cancer about 20-30 minutes of training during chemotherapy with the mobile health application and answering face-to-face questions about the use of mobile health application. 2. Sending a reminder message about the use of mobile health application via phone once a week. Answering the questions about the mobile health application and the training given during the chemotherapy application every two weeks / summarizing the training

Other: Colorectal-Mobile application

CONTROL

NO INTERVENTION

1. Giving approximately 20-30 minutes of routine treatment and care and answering questions during premedication application to colorectal cancer patients when they come to the unit to receive 1st cure chemotherapy. 2. Pre-test-post-test at the beginning of the 1st course of treatment and at the end of the 3rd cycle of treatment

Interventions

Colorectal-Mobile application OTHER

The use of Colorectal-Mobile application by the patients on a daily basis by the researcher will be monitored remotely via the management platform of the usage status of the mobile health application.

INTERFERENCE (EXPERIMENT)

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Chemotherapy was started with the diagnosis of colorectal cancer,
• Receiving adjuvant chemotherapy,
• His psychological and general condition is suitable for the interview and
• Identified as colorectal cancer patients who volunteered to participate in the study

You may not qualify if:

• Not diagnosed with colorectal cancer
• Not diagnosed adjuvant chemotherapy

Sponsors & Collaborators

• NESLISAH YASAR KARTAL: lead
• Saglik Bilimleri Universitesi: collaborator

Study Sites (1)

Beykent University

Istanbul, Buyukcekmece, 34528, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Colorectal Neoplasms; Cell Phone Use

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases; Communication; Behavior; Social Behavior

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Lecturer

Study Record Dates

• First Submitted: April 14, 2023
• First Posted: July 11, 2023
• Study Start: March 1, 2023
• Primary Completion: March 1, 2024
• Study Completion: January 14, 2025
• Last Updated: July 14, 2025

Record last verified: 2025-07

Locations

TU (1)